Intrinsic Value of S&P & Nasdaq Contact Us

NeurAxis, Inc. NRXS AMEX

American Stock Excha • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$8.00
+14.3%

NeurAxis, Inc. (NRXS) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

The consensus price target is $8.00, representing an upside of 14.3% from the current price $7.00.

Analysts estimate Earnings Per Share (EPS) of $-0.10 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.16 vs est $-0.10 (missed -1060%). 2025: actual $-0.95 vs est $-1.00 (beat +5%). Analyst accuracy: 52%.

NRXS Stock — 12-Month Price Forecast

$8.00
▲ +14.29% Upside
Average Price Target
Based on 1 Wall Street analysts offering 12-month price targets for NeurAxis, Inc., the price target is $8.00.
The average price target represents a +14.29% change from the last price of $7.00.

NRXS Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to NeurAxis, Inc. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — NRXS

52%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$1.16 vs Est –$0.10 ▼ 91.4% off
2025 Actual –$0.95 vs Est –$1.00 ▲ 5.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — NRXS

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.003B vs Est $0.012B ▼ 333.8% off
2025 Actual $0.004B vs Est $0.003B ▲ 3.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message